News Focus
News Focus
icon url

dennisdave

06/03/23 9:01 AM

#598013 RE: dstock07734 #598007

all nonrevenue cancer drug biotechs and their shareholders claim their platform is the best of the best unique and groundbreaking, one-of-a-kind, never seen before bla bla bla. Immunomedics claimed they were incredible and unique and their shareholders said it

NWBO shareholders saying it is no different.

I will say it too if that will x10 the SP :)